Frontiers in Pharmacology (Jul 2021)
Corrigendum: Tubeimoside 1 Acts as a Chemotherapeutic Synergist via Stimulating Macropinocytosis
- Xianling Gong,
- Xianling Gong,
- Ruibo Sun,
- Zhuowei Gao,
- Zhuowei Gao,
- Weili Han,
- Yawei Liu,
- Liang Zhao,
- Linlin Jing,
- Xueqing Yao,
- Xuegang Sun
Affiliations
- Xianling Gong
- The Key Laboratory of Molecular Biology, State Administration of Traditional Chinese Medicine, School of Traditional Chinese Medicine, Southern Medical University, Guangzhou, China
- Xianling Gong
- School of Pharmacy, Guangdong Medical University, Dongguan, China
- Ruibo Sun
- The Key Laboratory of Molecular Biology, State Administration of Traditional Chinese Medicine, School of Traditional Chinese Medicine, Southern Medical University, Guangzhou, China
- Zhuowei Gao
- The Key Laboratory of Molecular Biology, State Administration of Traditional Chinese Medicine, School of Traditional Chinese Medicine, Southern Medical University, Guangzhou, China
- Zhuowei Gao
- Shunde Hospital, Southern Medical University, Foshan, China
- Weili Han
- School of Public Health, Guangzhou, China
- Yawei Liu
- Nanfang Hospital, Southern Medical University, Guangzhou, China
- Liang Zhao
- School of Basic Medical Sciences, Southern Medical University, Guangzhou, China
- Linlin Jing
- Traditional Chinese Medicine Integrated Hospital, Southern Medical University, Guangzhou, China
- Xueqing Yao
- The Key Laboratory of Molecular Biology, State Administration of Traditional Chinese Medicine, School of Traditional Chinese Medicine, Southern Medical University, Guangzhou, China
- Xuegang Sun
- The Key Laboratory of Molecular Biology, State Administration of Traditional Chinese Medicine, School of Traditional Chinese Medicine, Southern Medical University, Guangzhou, China
- DOI
- https://doi.org/10.3389/fphar.2021.730775
- Journal volume & issue
-
Vol. 12
Abstract
No abstracts available.Keywords
